These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23981262)

  • 21. Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
    Pottegård A; Friis S; Stürmer T; Hallas J; Bahmanyar S
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):451-459. PubMed ID: 29265740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan.
    Ishiguro C; Takeuchi Y; Uyama Y; Tawaragi T
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):854-9. PubMed ID: 27222073
    [No Abstract]   [Full Text] [Related]  

  • 23. Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example.
    Rawson NS
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1072-9. PubMed ID: 19650154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacoepidemiology 101: data monitoring committees in the post-marketing approval setting.
    Lilienfeld DE
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):381-5. PubMed ID: 15170767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on method on post-marketing traditonal Chinese medicine safety assessment].
    Kou Q; Zhao S; Feng G; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2771-5. PubMed ID: 22292361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [From a Viewpoint of Clinical Settings: Pharmacoepidemiology as Reverse Translational Research (rTR)].
    Kawakami J
    Yakugaku Zasshi; 2017; 137(6):681-683. PubMed ID: 28566573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of self-controlled designs in pharmacoepidemiology.
    Hallas J; Pottegård A
    J Intern Med; 2014 Jun; 275(6):581-9. PubMed ID: 24635348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of pharmacoepidemiology in three bibliographic databases: Medline, IPA and SCI.
    Arrebola-Pascual I; García-López JA
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):499-502. PubMed ID: 12426935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of pharmacoepidemiology in pregnancy-implications for safety.
    Benevent J; Montastruc F; Damase-Michel C
    Expert Opin Drug Saf; 2017 Oct; 16(10):1181-1190. PubMed ID: 28777918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The case-crossover study design in pharmacoepidemiology.
    Delaney JA; Suissa S
    Stat Methods Med Res; 2009 Feb; 18(1):53-65. PubMed ID: 18765504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A history of pharmacoepidemiology.
    Bégaud B
    Therapie; 2019 Apr; 74(2):175-179. PubMed ID: 30392701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics.
    Kaguelidou F; Durrieu G; Clavenna A
    Therapie; 2019 Apr; 74(2):315-324. PubMed ID: 30773345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaches to combat with confounding by indication in observational studies of intended drug effects.
    McMahon AD
    Pharmacoepidemiol Drug Saf; 2003; 12(7):551-8. PubMed ID: 14558178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study.
    Sakuma M; Bates DW; Morimoto T
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1221-6. PubMed ID: 22887972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoepidemiological safety studies in children: a systematic review.
    Osokogu OU; Dukanovic J; Ferrajolo C; Dodd C; Pacurariu AC; Bramer WM; 'tJong G; Weibel D; Sturkenboom MC; Kaguelidou F
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):861-70. PubMed ID: 27255559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacoepidemiology in older people: Purposes and future directions.
    Laroche ML; Sirois C; Reeve E; Gnjidic D; Morin L
    Therapie; 2019 Apr; 74(2):325-332. PubMed ID: 30773343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research in pharmacoepidemiology in Iceland].
    Johannsson M; Haraldsdottir S
    Laeknabladid; 2012 Apr; 98(4):217-22. PubMed ID: 22460435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research Techniques Made Simple: Pharmacoepidemiology Research Methods in Dermatology.
    Noe MH; Gelfand JM
    J Invest Dermatol; 2018 Feb; 138(2):e13-e18. PubMed ID: 29389330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industry.
    Quartey G; Wang J; Kim J
    Pharm Stat; 2011; 10(6):548-53. PubMed ID: 22127819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Record linkage for pharmacoepidemiological studies in cancer patients.
    Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.